These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30202929)

  • 21. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CRISPR-baby scandal: what's next for human gene-editing.
    Cyranoski D
    Nature; 2019 Feb; 566(7745):440-442. PubMed ID: 30809070
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethics in embryo research: a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee.
    ; ;
    Fertil Steril; 2020 Feb; 113(2):270-294. PubMed ID: 32106974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editing the human genome: where ART and science intersect.
    Hershlag A; Bristow SL
    J Assist Reprod Genet; 2018 Aug; 35(8):1367-1370. PubMed ID: 29882090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Editing: Promoting Responsible Research.
    Hirsch F; Lemaitre C; Chneiweiss H; Montoliu L
    Pharmaceut Med; 2019 Jun; 33(3):187-191. PubMed ID: 31933285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
    Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. After the Storm - A Responsible Path for Genome Editing.
    Daley GQ; Lovell-Badge R; Steffann J
    N Engl J Med; 2019 Mar; 380(10):897-899. PubMed ID: 30649993
    [No Abstract]   [Full Text] [Related]  

  • 28. Query the merits of embryo editing for reproductive research now.
    Hyun I; Osborn C
    Nat Biotechnol; 2017 Nov; 35(11):1023-1025. PubMed ID: 29121025
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control (editing) of the genome within reach, or already in our hands?].
    Brdička R; Omelka R
    Cas Lek Cesk; 2018; 157(2):79-83. PubMed ID: 29790357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Nuffield Council's green light for genome editing human embryos defies fundamental human rights law.
    Drabiak K
    Bioethics; 2020 Mar; 34(3):223-227. PubMed ID: 31943263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
    Baylis F; Darnovsky M; Hasson K; Krahn TM
    CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narrow path charted for editing genes of human embryos.
    Cohen J
    Science; 2020 Sep; 369(6509):1283. PubMed ID: 32913081
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene Editing in Humans: Towards a Global and Inclusive Debate for Responsible Research.
    de Lecuona I; Casado M; Marfany G; Lopez Baroni M; Escarrabill M
    Yale J Biol Med; 2017 Dec; 90(4):673-681. PubMed ID: 29259532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
    Tyagi S; Kumar R; Das A; Won SY; Shukla P
    J Biotechnol; 2020 Aug; 319():36-53. PubMed ID: 32446977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Future of Gene Editing - Toward Scientific and Social Consensus.
    Rosenbaum L
    N Engl J Med; 2019 Mar; 380(10):971-975. PubMed ID: 30649992
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo genome editing targeted towards the female reproductive system.
    Sato M; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Gurumurthy CB
    Arch Pharm Res; 2018 Sep; 41(9):898-910. PubMed ID: 29974342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
    Isa NM; Zulkifli NA; Man S
    Sci Eng Ethics; 2020 Feb; 26(1):309-323. PubMed ID: 30830592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The technical risks of human gene editing.
    Davies B
    Hum Reprod; 2019 Nov; 34(11):2104-2111. PubMed ID: 31696232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
    Musunuru K
    JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.